CVE:NU NeutriSci International (NU) Stock Price, News & Analysis → Protect Your Bank Account Before It’s Too Late (From Weiss Ratings) (Ad) Free NU Stock Alerts C$0.0050 -0.01 (-50.00%) (As of 05/6/2024) Add Compare Share Share Today's RangeC$0.01▼C$0.0150-Day RangeC$0.01▼C$0.0152-Week RangeC$0.01▼C$0.02Volume105,000 shsAverage Volume55,311 shsMarket CapitalizationC$892,100.00P/E RatioN/ADividend Yield2.61%Price TargetN/A Stock AnalysisStock AnalysisChartStock AnalysisChart Ad Porter & CompanyElon to Transform U.S. Economy? A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” grift of the elites. And yet, while it threatens their wealth and power, it could be transformational for both the U.S. economy and your wealth.One company holds a near-total monopoly on it. About NeutriSci InternationalNeutriSci International Inc. develops and markets nutraceutical products in Canada, Germany, and Japan. It offers neuenergy, an energy tab designed to deliver enhanced focus and mental clarity. The company sells its products through a distribution network of retail storefront and online markets. NeutriSci International Inc. was incorporated in 2009 and is headquartered in Vancouver, Canada.Read More NU Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart NU Stock News HeadlinesMarch 27, 2023 | marketwatch.comMedical Nebulizer Market Outlook and Forecast till 2031September 22, 2021 | apnews.comNeutriSci Receives Additional Purchase Order and Deposit from Tabletz Distribution PartnerSeptember 11, 2021 | apnews.comNeutriSci Arranges Strategic Financing with Tabletz and Exercise of WarrantsSee More Headlines Company Calendar Today5/18/2024Next Earnings (Estimated)5/23/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeCVE SectorMedical Industry Drug Manufacturers - Specialty & Generic Sub-IndustryN/A Current SymbolCVE:NU CUSIPN/A CIKN/A Webwww.neutrisci.com Phone403-264-6320FaxN/AEmployees147,000Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on Assets-175.93% Debt Debt-to-Equity Ratio20.93 Current Ratio0.02 Quick Ratio0.02 Sales & Book Value Annual SalesC$432,451.00 Price / Sales2.06 Cash FlowC$0.00 per share Price / Cash Flow25.00 Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares178,420,000Free FloatN/AMarket CapC$892,100.00 OptionableNot Optionable Beta0.82 Key ExecutivesMr. Glen RehmanCEO, President & DirectorMr. John Robert Chisholm (Age 62)Chief Financial Officer Ms. Jaycee WatersOperations & Logistics ManagerMr. Thierry SorhaitzVice President of Sales & MarketingKey CompetitorsSugarBud Craft GrowersCVE:SUGRAvivagenCVE:VIVRadient TechnologiesCVE:RTIAcerus PharmaceuticalsTSE:ASPAequus PharmaceuticalsCVE:AQSView All Competitors NU Stock Analysis - Frequently Asked Questions How have NU shares performed in 2024? NeutriSci International's stock was trading at C$0.01 at the beginning of 2024. Since then, NU shares have increased by 0.0% and is now trading at C$0.01. View the best growth stocks for 2024 here. When is NeutriSci International's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Thursday, May 23rd 2024. View our NU earnings forecast. What other stocks do shareholders of NeutriSci International own? Based on aggregate information from My MarketBeat watchlists, some companies that other NeutriSci International investors own include EMCOR Group (EME), Incyte (INCY), Northwest Pipe (NWPX), UnitedHealth Group (UNH), Watsco (WSO), Zimmer Biomet (ZBH), 3i Infrastructure (3IN), Axos Financial (AX) and Actinium Pharmaceuticals (ATNM). How do I buy shares of NeutriSci International? Shares of NU stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.Compare Top Brokerages Here. This page (CVE:NU) was last updated on 5/18/2024 by MarketBeat.com Staff From Our PartnersObama’s Forever Term [exposed]Porter & CompanyCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaMissed NVDA? Buy this AI stock NOWChaikin AnalyticsMost important medical advance in 100 yearsThe Oxford ClubThe Presidential candidate you should REALLY be worried aboutStansberry ResearchForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressShocking: One AI startup's revenue could surge 4,735%Manward Press Adding Choose a watchlist: Watchlist My Default Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Questions? Get Started with MarketBeat — Read Your Daily NewsletterCheck Out My MarketBeatWatch Our Tutorial VideosAdd a Stock to Your WatchlistSet Up an Instant AlertView a Company's Profile PageView Our Financial CalendarsView Today's Analyst Ratings Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.